4.90MMarket Cap-112P/E (TTM)
0.7664High0.6875Low393.03KVolume0.7189Open0.6770Pre Close286.65KTurnover6.34%Turnover RatioLossP/E (Static)6.88MShares5.239952wk High0.41P/B4.42MFloat Cap0.602052wk Low--Dividend TTM6.20MShs Float59.5990Historical High--Div YieldTTM11.65%Amplitude0.6020Historical Low0.7290Avg Price1Lot Size
Petros Pharmaceuticals Stock Forum
NEWS
Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
4 MINUTES AGO, 9:15 AM EDT
VIA ACCESSWIRE
Petros Pharmaceuticals has shared positive outcomes from a crucial Phase 2-equivalent study for STENDRA(R) (avanafil), marking a significant milestone in the medication's journey towards over-the-counter (OTC) availability. This innovative study paves the way for enhancing accessibility to treatment options for erectile dysfunction (ED), p...
Accesswire· 5 mins ago
No comment yet